Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2004

View Archived Issues

Eisai assumes distribution responsibilities for Aciphex

Kyorin Pharmaceutical to tie up with ActivX Bioscience

BioPort signs contract to supply anthrax vaccine

Dyax and Baxter to collaborate in MIF antibody research

Innovative Companies files patent for method to stabilize levothyroxine

KaloBios and Celscia Therapeutics close merger

Morphotek and NCI sign agreement to develop antibodies for the treatment of various cancers

Amgen claims two series of calcium channel modulators for bone and PTH disorders

JT team presents MTP inhibitors devoid of hepatic side effects

New etonogestrel esters and their use presented by Akzo Nobel scientists

Novel factor Xa inhibitors prepared and tested at Boehringer Ingelheim

New adenosine A3 ligands jointly reported by Solvay and ArQule

Lilly claims new opioid antagonists with utility in obesity and related disorders

Novel protein kinase inhibitors for cancer and neurological disorders

Phase Ib trial evaluates WX-UK1 in head and neck cancer patients

Phase II trial design agreed for InKine's new generation purgative product

Phase I/II HGTV43 gene construct study commences

Pivotal Fibrillex study cleared to continue by DSMB

Axcan submits sNDA for 1g mesalamine suppository

Zyprexa approved for maintenance in bipolar disorder treatment

Remoxy advances into phase I

New expanded indication for Lamictal

Chiron HIV vaccine enters phase I trial

Procleix Ultrio Assay receives European CE Mark

Phase I inhaled doripenem trial commences enrollment

Improved survival found with Provenge(R) in patients with advanced prostate cancer

Significant improvements induced by renzapride in IBS

Dalbavancin reported more effective than vancomycin against catheter-related bloodstream infections

Evidence of antifungal activity found for Thymus essential oils

Topical imiquimod found safe and effective in squamous cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...